Clinical parameters | OS | PFS | ||||
---|---|---|---|---|---|---|
No a | HR (95% CI) b | p | No a | HR (95% CI) b | p | |
Age | Â | Â | 0.660 | Â | Â | 0.592 |
 ≤ 60 years | 46 | 1 |  | 41 | 1 |  |
 > 60 years | 63 | 1.13 (0.65–1.96) |  | 57 | 0.87 (0.53–1.44) |  |
Residual tumor mass |  |  | < 0.001 |  |  | 0.005 |
 0 mm | 59 | 1 |  | 57 | 1 |  |
 > 0 mm | 50 | 3.29 (1.69–6.41) |  | 41 | 2.20 (1.17–3.81) |  |
Ascitic fluid volume | Â | Â | 0.605 | Â | Â | 0.363 |
 ≤ 500 ml | 64 | 1 |  | 60 | 1 |  |
 > 500 ml | 45 | 1.18 (0.64–1.91) |  | 38 | 1.33 (0.76–2.31) |  |
KLK5 mRNA c | Â | Â | 0.718 | Â | Â | 0.095 |
 low | 69 | 1 |  | 59 | 1 |  |
 high | 40 | 1.11 (0.64–1.91) |  | 39 | 1.53 (0.93–2.51) |  |